C. Juan

发表

Extended-spectrum beta-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2.

J. Campos, A. Oliver, M. Pérez-Vázquez, 2009, International journal of antimicrobial agents.

Activity of mammalian peptidoglycan-targeting immunity against Pseudomonas aeruginosa.

A. Oliver, C. Juan, Gabriel Torrens, 2020, Journal of medical microbiology.

Profiling the susceptibility of Pseudomonas aeruginosa strains from acute and chronic infections to cell-wall-targeting immune proteins

A. Oliver, C. Juan, Gabriel Torrens, 2019, Scientific Reports.

Interplay between Peptidoglycan Biology and Virulence in Gram-Negative Pathogens

A. Oliver, C. Juan, Gabriel Torrens, 2018, Microbiology and Molecular Biology Reviews.

Targeting the permeability barrier and peptidoglycan recycling pathways to disarm Pseudomonas aeruginosa against the innate immune system

A. Oliver, J. Blázquez, J. Ayala, 2017, PloS one.

Transferable Multidrug Resistance Plasmid Carrying cfr Associated with tet(L), ant(4′)-Ia, and dfrK Genes from a Clinical Methicillin-Resistant Staphylococcus aureus ST125 Strain

A. Oliver, C. Juan, E. Ruíz de Gopegui, 2012, Antimicrobial Agents and Chemotherapy.

In vivo validation of peptidoglycan recycling as target to disable AmpC-mediated resistance and reduce virulence enhancing the cell-wall-targeting immunity.

A. Oliver, C. Juan, Gabriel Torrens, 2019, The Journal of infectious diseases.

Nosocomial Spread of Colistin-Only-Sensitive Sequence Type 235 Pseudomonas aeruginosa Isolates Producing the Extended-Spectrum β-Lactamases GES-1 and GES-5 in Spain

A. Oliver, J. Otero, J. Acosta, 2009, Antimicrobial Agents and Chemotherapy.

Pseudomonas aeruginosa producing the extended-spectrum β-

A. Oliver, J. Acosta, E. Viedma, 2009 .

Affinity of the New Cephalosporin CXA-101 to Penicillin-Binding Proteins of Pseudomonas aeruginosa

A. Oliver, C. Juan, B. Moyá, 2010, Antimicrobial Agents and Chemotherapy.

Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa Isolates from Spanish Hospitals

A. Oliver, E. Bouza, E. Cercenado, 2007, Antimicrobial Agents and Chemotherapy.

Mammals' humoral immune proteins and peptides targeting the bacterial envelope: from natural protection to therapeutic applications against multidrug‐resistant Gram‐negatives

A. Oliver, C. Juan, Gabriel Torrens, 2022, Biological reviews of the Cambridge Philosophical Society.

Pathogenic characteristics of Pseudomonas aeruginosa bacteraemia isolates in a high-endemicity setting for ST175 and ST235 high-risk clones

A. Oliver, E. Viedma, F. Chaves, 2019, European Journal of Clinical Microbiology & Infectious Diseases.

Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania

A. Oliver, X. Mulet, A. Vitkauskienė, 2015, European Journal of Clinical Microbiology & Infectious Diseases.

A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition

A. Oliver, C. Suárez, J. Ariza, 2011, BMC infectious diseases.

Detection of the Novel Extended-Spectrum β-Lactamase OXA-161 from a Plasmid-Located Integron in Pseudomonas aeruginosa Clinical Isolates from Spain

A. Oliver, X. Mulet, J. Pérez, 2009, Antimicrobial Agents and Chemotherapy.

Nosocomial Outbreak of a Non-Cefepime-Susceptible Ceftazidime-Susceptible Pseudomonas aeruginosa Strain Overexpressing MexXY-OprM and Producing an Integron-Borne PSE-1 ß-Lactamase

A. Oliver, C. Suárez, J. Ariza, 2009, Journal of Clinical Microbiology.

Contribution of clonal dissemination and selection of mutants during therapy to Pseudomonas aeruginosa antimicrobial resistance in an intensive care unit setting.

A. Oliver, J. Pérez, N. Borrell, 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

In Vivo Emergence of Resistance to Novel Cephalosporin–β-Lactamase Inhibitor Combinations through the Duplication of Amino Acid D149 from OXA-2 β-Lactamase (OXA-539) in Sequence Type 235 Pseudomonas aeruginosa

A. Oliver, X. Mulet, C. Juan, 2017, Antimicrobial Agents and Chemotherapy.

Effects of Inhaled Corticosteroids on the Innate Immunological Response to Pseudomonas aeruginosa Infection in Patients with COPD

B. Cosío, C. Juan, Maria Escobar-Salom, 2022, International journal of molecular sciences.

Impact of Peptidoglycan Recycling Blockade and Expression of Horizontally Acquired β-Lactamases on Pseudomonas aeruginosa Virulence

A. Oliver, X. Mulet, C. Juan, 2022, Microbiology spectrum.

β-Lactam Resistance Response Triggered by Inactivation of a Nonessential Penicillin-Binding Protein

A. Oliver, Andreas Dötsch, J. Blázquez, 2009, PLoS pathogens.

Stepwise Upregulation of the Pseudomonas aeruginosa Chromosomal Cephalosporinase Conferring High-Level β-Lactam Resistance Involves Three AmpD Homologues

A. Oliver, C. Juan, B. Moyá, 2006, Antimicrobial Agents and Chemotherapy.

Molecular Mechanisms of β-Lactam Resistance Mediated by AmpC Hyperproduction in Pseudomonas aeruginosa Clinical Strains

M. Maciá, A. Oliver, C. Juan, 2005, Antimicrobial Agents and Chemotherapy.

Activity of a New Cephalosporin, CXA-101 (FR264205), against β-Lactam-Resistant Pseudomonas aeruginosa Mutants Selected In Vitro and after Antipseudomonal Treatment of Intensive Care Unit Patients

A. Oliver, C. Juan, B. Moyá, 2010, Antimicrobial Agents and Chemotherapy.

Afﬁnity of the New Cephalosporin CXA-101 to Penicillin-Binding Proteins of Pseudomonas aeruginosa (cid:1)

A. Oliver, C. Juan, B. Moyá, 2010 .

Benefit of Having Multiple ampD Genes for Acquiring β-Lactam Resistance without Losing Fitness and Virulence in Pseudomonas aeruginosa

A. Oliver, C. Juan, B. Moyá, 2008, Antimicrobial Agents and Chemotherapy.

Beneﬁt of Having Multiple ampD Genes for Acquiring (cid:2) -Lactam Resistance without Losing Fitness and Virulence in Pseudomonas aeruginosa (cid:1)

A. Oliver, C. Juan, B. Moyá, 2008 .

Pan-β-Lactam Resistance Development in Pseudomonas aeruginosa Clinical Strains: Molecular Mechanisms, Penicillin-Binding Protein Profiles, and Binding Affinities

A. Oliver, A. Beceiro, C. Juan, 2012, Antimicrobial Agents and Chemotherapy.

Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.

A. Oliver, X. Mulet, R. del Campo, 2011, The Journal of antimicrobial chemotherapy.

Sensing Mg2+ contributes to the resistance of Pseudomonas aeruginosa to complement‐mediated opsonophagocytosis

J. Goldberg, R. Hancock, Mohammad Qadi, 2017, Environmental microbiology.

Chronic Respiratory Infections by Mucoid Carbapenemase-Producing Pseudomonas aeruginosa Strains, a New Potential Public Health Problem

A. Oliver, F. Renom, M. Garau, 2008, Antimicrobial Agents and Chemotherapy.

Antagonistic Interactions of Pseudomonas aeruginosa Antibiotic Resistance Mechanisms in Planktonic but Not Biofilm Growth

M. Maciá, A. Oliver, X. Mulet, 2011, Antimicrobial Agents and Chemotherapy.

Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones.

A. Oliver, C. Juan, A. Mena, 2010, The Journal of antimicrobial chemotherapy.

Regulation of AmpC-Driven β-Lactam Resistance in Pseudomonas aeruginosa: Different Pathways, Different Signaling

A. Oliver, F. Cava, Sara B. Hernández, 2019, mSystems.

Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa

A. Oliver, X. Mulet, C. Juan, 2018, The Journal of antimicrobial chemotherapy.

Deciphering the resistome of the widespread P. aeruginosa ST175 international high-risk clone through whole genome sequencing

A. Oliver, L. Martínez-Martínez, F. Tubau, 2018 .

Comparison of Local Features from Two Spanish Hospitals Reveals Common and Specific Traits at Multiple Levels of the Molecular Epidemiology of Metallo-β-Lactamase-Producing Pseudomonas spp

A. Oliver, C. Seral, F. Castillo, 2014, Antimicrobial Agents and Chemotherapy.

First detection in Europe of the metallo-β-lactamase IMP-15 in clinical strains of Pseudomonas putida and Pseudomonas aeruginosa.

A. Oliver, J. Castillo-Vera, C. Juan, 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Challenges for accurate susceptibility testing, detection and interpretation of β-lactam resistance phenotypes in Pseudomonas aeruginosa: results from a Spanish multicentre study.

A. Oliver, Á. Pascual, C. Gimeno, 2013, The Journal of antimicrobial chemotherapy.

Pan-β-lactam Resistance Development in Pseudomonas aeruginosa 1 Clinical Strains : Molecular Mechanisms , PBPs Profiles and Binding 2 Affinities

A. Oliver, A. Beceiro, C. Juan, 2012 .

AmpG Inactivation Restores Susceptibility of Pan-β-Lactam-Resistant Pseudomonas aeruginosa Clinical Strains

A. Oliver, D. Vocadlo, B. Mark, 2011, Antimicrobial Agents and Chemotherapy.

Differential beta-lactam resistance response driven by ampD or dacB (PBP4) inactivation in genetically diverse Pseudomonas aeruginosa strains.

A. Oliver, C. Juan, B. Moyá, 2010, The Journal of antimicrobial chemotherapy.

NagZ Inactivation Prevents and Reverts β-Lactam Resistance, Driven by AmpD and PBP 4 Mutations, in Pseudomonas aeruginosa

A. Oliver, D. Vocadlo, B. Mark, 2010, Antimicrobial Agents and Chemotherapy.

NagZ Inactivation Prevents and Reverts (cid:1) -Lactam Resistance, Driven by AmpD and PBP 4 Mutations, in Pseudomonas aeruginosa (cid:1)

A. Oliver, D. Vocadlo, B. Mark, 2010 .

Activity of a New Antipseudomonal Cephalosporin, CXA-101 (FR264205), against Carbapenem-Resistant and Multidrug-Resistant Pseudomonas aeruginosa Clinical Strains

A. Oliver, C. Juan, L. Zamorano, 2009, Antimicrobial Agents and Chemotherapy.

Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa Isolates from Spanish Hospitals (cid:1)

A. Oliver, E. Bouza, E. Cercenado, 2007 .

Proteomics evaluation of enniatins acute toxicity in rat liver.

G. Font, C. Juan, L. Manyes, 2021, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

Optimizing the management of Pseudomonas aeruginosa infections with tools for the detection of resistance mechanisms and pharmacokinetic/pharmacodynamic (PK/PD) analysis

C. Juan, 2019, Enfermedades infecciosas y microbiologia clinica (English ed.).

Optimizing the management of Pseudomonas aeruginosa infections with tools for the detection of resistance mechanisms and pharmacokinetic/pharmacodynamic (PK/PD) analysis.

C. Juan, 2019, Enfermedades infecciosas y microbiologia clinica.

Role of Enzymatic Activity in the Biological Cost Associated with the Production of AmpC β-Lactamases in Pseudomonas aeruginosa

A. Oliver, X. Mulet, C. Juan, 2022, Microbiology spectrum.

Comparative Analysis of Peptidoglycans From Pseudomonas aeruginosa Isolates Recovered From Chronic and Acute Infections

A. Oliver, C. Juan, Gabriel Torrens, 2019, Front. Microbiol..

The increasing threat of Pseudomonas aeruginosa high-risk clones.

Carlos Juan, Antonio Oliver, Xavier Mulet, 2015, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

VIM-47, a New Variant of the Autochthonous Metallo-β-Lactamase VIM-13 from the Balearic Islands in Spain

A. Oliver, X. Mulet, M. Garau, 2016, Antimicrobial Agents and Chemotherapy.

Draft Genome Sequence of Colistin-Only-Susceptible Pseudomonas aeruginosa Strain ST235, a Hypervirulent High-Risk Clone in Spain

A. Oliver, E. Viedma, F. Chaves, 2014, Genome Announcements.

Draft Genome Sequence of VIM-2-Producing Multidrug-Resistant Pseudomonas aeruginosa ST175, an Epidemic High-Risk Clone

A. Oliver, J. Otero, E. Viedma, 2013, Genome Announcements.

Environmental Microbiota Represents a Natural Reservoir for Dissemination of Clinically Relevant Metallo-β-Lactamases

A. Oliver, J. Lalucat, C. Juan, 2011, Antimicrobial Agents and Chemotherapy.

Characterization of the New Metallo-β-Lactamase VIM-13 and Its Integron-Borne Gene from a Pseudomonas aeruginosa Clinical Isolate in Spain

A. Oliver, G. Bou, A. Beceiro, 2008, Antimicrobial Agents and Chemotherapy.

Role of Klebsiella pneumoniae LamB Porin in Antimicrobial Resistance

A. Doménech-Sánchez, C. Juan, S. Albertí, 2011, Antimicrobial Agents and Chemotherapy.

Pseudomonas aeruginosa Ceftolozane-Tazobactam Resistance Development Requires Multiple Mutations Leading to Overexpression and Structural Modification of AmpC

A. Oliver, X. Mulet, Sebastian Bruchmann, 2014, Antimicrobial Agents and Chemotherapy.

Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections.

A. Oliver, C. Juan, C. Peña, 2017, The Journal of infectious diseases.

Diversity and regulation of intrinsic β-lactamases from non-fermenting and other Gram-negative opportunistic pathogens.

A. Oliver, C. Juan, Gabriel Torrens, 2017, FEMS microbiology reviews.

In vitro dynamics and mechanisms of resistance development to imipenem and imipenem/relebactam in Pseudomonas aeruginosa.

A. Oliver, C. Juan, B. Moyá, 2020, The Journal of antimicrobial chemotherapy.

Genetic Markers of Widespread Extensively Drug-Resistant Pseudomonas aeruginosa High-Risk Clones

A. Oliver, C. Rodriguez, L. Martínez-Martínez, 2012, Antimicrobial Agents and Chemotherapy.

Synergistic activity of fosfomycin, &bgr;-lactams and peptidoglycan recycling inhibition against Pseudomonas aeruginosa

A. Oliver, J. Blázquez, Mitchell Hattie, 2017, The Journal of antimicrobial chemotherapy.

Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing

A. Oliver, C. Rodriguez, L. Martínez-Martínez, 2016, Antimicrobial Agents and Chemotherapy.

Synthesis and Antimicrobial Studies of New Antibacterial Azo-Compounds Active against Staphylococcus aureus and Listeria monocytogenes

S. Piotto, S. Concilio, L. Sessa, 2017, Molecules.

Biological Markers of Pseudomonas aeruginosa Epidemic High-Risk Clones

A. Oliver, X. Mulet, C. Rodriguez, 2013, Antimicrobial Agents and Chemotherapy.

Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates

A. Oliver, J. Blázquez, A. Navas, 2015, Antimicrobial Agents and Chemotherapy.

Structure and interaction with phospholipids of a prokaryotic lipoxygenase from Pseudomonas aeruginosa

A. Oliver, A. Garreta, A. Ortiz, 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

The Pseudomonas aeruginosa CreBC Two-Component System Plays a Major Role in the Response to β-Lactams, Fitness, Biofilm Growth, and Global Regulation

A. Oliver, X. Mulet, J. Blázquez, 2014, Antimicrobial Agents and Chemotherapy.

Impact of AmpC Derepression on Fitness and Virulence: the Mechanism or the Pathway?

A. Oliver, S. Normark, P. Mellroth, 2016, mBio.

Mobile Genetic Elements Related to the Diffusion of Plasmid-Mediated AmpC β-Lactamases or Carbapenemases from Enterobacteriaceae: Findings from a Multicenter Study in Spain

A. Oliver, B. Aracil, G. Bou, 2015, Antimicrobial Agents and Chemotherapy.

OmpK26, a Novel Porin Associated with Carbapenem Resistance in Klebsiella pneumoniae

M. Barbier, A. Doménech-Sánchez, C. Juan, 2011, Antimicrobial Agents and Chemotherapy.

Bacterial virulence regulation through soluble peptidoglycan fragments sensing and response: knowledge gaps and therapeutic potential

A. Oliver, C. Juan, Gabriel Torrens, 2023, FEMS microbiology reviews.

6-Halopyridylmethylidene Penicillin-Based Sulfones Efficiently Inactivate the Natural Resistance of Pseudomonas aeruginosa to β-Lactam Antibiotics.

A. Oliver, C. González‐Bello, G. Bou, 2021, Journal of medicinal chemistry.

Azithromycin in Pseudomonas aeruginosa Biofilms: Bactericidal Activity and Selection of nfxB Mutants

M. Maciá, A. Oliver, X. Mulet, 2009, Antimicrobial Agents and Chemotherapy.

Impact of multidrug resistance on the pathogenicity of Pseudomonas aeruginosa: in vitro and in vivo studies.

A. Oliver, J. Ariza, F. Tubau, 2016, International journal of antimicrobial agents.

Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-beta-lactamases.

A. Oliver, G. Bou, F. Kerff, 2010, The Journal of antimicrobial chemotherapy.

Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania

A. Oliver, X. Mulet, A. Vitkauskienė, 2016, European Journal of Clinical Microbiology & Infectious Diseases.

Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-β-lactamases—authors' response

A. Oliver, G. Bou, F. Kerff, 2011 .

Characterization of plasmids encoding blaESBL and surrounding genes in Spanish clinical isolates of Escherichia coli and Klebsiella pneumoniae.

J. Campos, A. Oliver, M. Pérez-Vázquez, 2008, The Journal of antimicrobial chemotherapy.

Activity of the new cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa isolates from chronically-infected cystic fibrosis patients.

A. Oliver, R. Cantón, C. Juan, 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

VIM-2–producing Multidrug-Resistant Pseudomonas aeruginosa ST175 Clone, Spain

A. Oliver, J. Otero, E. Viedma, 2012, Emerging infectious diseases.

Hypermutation and the Preexistence of Antibiotic-Resistant Pseudomonas aeruginosa Mutants: Implications for Susceptibility Testing and Treatment of Chronic Infections

B. Levin, A. Oliver, F. Baquero, 2004, Antimicrobial Agents and Chemotherapy.

Lack of Association between Hypermutation and Antibiotic Resistance Development in Pseudomonas aeruginosa Isolates from Intensive Care Unit Patients

A. Oliver, C. Juan, O. Gutiérrez, 2004, Antimicrobial Agents and Chemotherapy.

Inhaled corticosteroid dose is associated with Pseudomonas aeruginosa infection in severe COPD

B. Cosío, C. Juan, C. López-Causapé, 2021, BMJ Open Respiratory Research.

Activity of the new cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa isolates from chronically-infected cystic fibrosis patients.

A. Oliver, R. Cantón, C. Juan, 2010, Clinical Microbiology and Infection.

PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa

A. Oliver, V. Kapur, J. Blázquez, 2006, Molecular microbiology.